BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 23042511)

  • 1. Nitric oxide prevents atorvastatin-induced skeletal muscle dysfunction and alterations in mice.
    D'Antona G; Mascaro A; Monopoli A; Miglietta D; Ongini E; Bottinelli R
    Muscle Nerve; 2013 Jan; 47(1):72-80. PubMed ID: 23042511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coenzyme Q10 reverses mitochondrial dysfunction in atorvastatin-treated mice and increases exercise endurance.
    Muraki A; Miyashita K; Mitsuishi M; Tamaki M; Tanaka K; Itoh H
    J Appl Physiol (1985); 2012 Aug; 113(3):479-86. PubMed ID: 22653988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NCX 6560, a nitric oxide-releasing derivative of atorvastatin, inhibits cholesterol biosynthesis and shows anti-inflammatory and anti-thrombotic properties.
    Momi S; Impagnatiello F; Guzzetta M; Caracchini R; Guglielmini G; Olivieri R; Monopoli A; Gresele P
    Eur J Pharmacol; 2007 Sep; 570(1-3):115-24. PubMed ID: 17632098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atorvastatin and pitavastatin enhance lipoprotein lipase production in L6 skeletal muscle cells through activation of adenosine monophosphate-activated protein kinase.
    Ohira M; Endo K; Saiki A; Miyashita Y; Terai K; Murano T; Watanabe F; Tatsuno I; Shirai K
    Metabolism; 2012 Oct; 61(10):1452-60. PubMed ID: 22520230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose statins and skeletal muscle metabolism in humans: a randomized, controlled trial.
    Päivä H; Thelen KM; Van Coster R; Smet J; De Paepe B; Mattila KM; Laakso J; Lehtimäki T; von Bergmann K; Lütjohann D; Laaksonen R
    Clin Pharmacol Ther; 2005 Jul; 78(1):60-8. PubMed ID: 16003294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondria of trained skeletal muscle are protected from deleterious effects of statins.
    Bouitbir J; Daussin F; Charles AL; Rasseneur L; Dufour S; Richard R; Piquard F; Geny B; Zoll J
    Muscle Nerve; 2012 Sep; 46(3):367-73. PubMed ID: 22907227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atorvastatin protects obese mice against hepatic ischemia-reperfusion injury by Toll-like receptor-4 suppression and endothelial nitric oxide synthase activation.
    Ajamieh H; Farrell G; Wong HJ; Yu J; Chu E; Chen J; Teoh N
    J Gastroenterol Hepatol; 2012 Aug; 27(8):1353-61. PubMed ID: 22432744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial nitric oxide synthase (NOS) deficiency affects energy metabolism pattern in murine oxidative skeletal muscle.
    Momken I; Fortin D; Serrurier B; Bigard X; Ventura-Clapier R; Veksler V
    Biochem J; 2002 Nov; 368(Pt 1):341-7. PubMed ID: 12123418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitric oxide enhances the anti-inflammatory and anti-atherogenic activity of atorvastatin in a mouse model of accelerated atherosclerosis.
    Momi S; Monopoli A; Alberti PF; Falcinelli E; Corazzi T; Conti V; Miglietta D; Ongini E; Minuz P; Gresele P
    Cardiovasc Res; 2012 Jun; 94(3):428-38. PubMed ID: 22362817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of atorvastatin on energy expenditure and skeletal muscle oxidative metabolism at rest and during exercise.
    Chung J; Brass EP; Ulrich RG; Hiatt WR
    Clin Pharmacol Ther; 2008 Feb; 83(2):243-50. PubMed ID: 17554242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atorvastatin delays murine platelet activation in vivo even in the absence of endothelial NO synthase.
    Ni R; Peleg T; Gross PL
    Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2609-15. PubMed ID: 22995523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atorvastatin treatment attenuates motor neuron degeneration in wobbler mice.
    Iwamoto K; Yoshii Y; Ikeda K
    Amyotroph Lateral Scler; 2009; 10(5-6):405-9. PubMed ID: 19922131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atorvastatin restores the impaired vascular endothelium-dependent relaxations mediated by nitric oxide and endothelium-derived hyperpolarizing factors but not hypotension in sepsis.
    Subramani J; Kathirvel K; Leo MD; Kuntamallappanavar G; Uttam Singh T; Mishra SK
    J Cardiovasc Pharmacol; 2009 Dec; 54(6):526-34. PubMed ID: 19755915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HMG-CoA reductase inhibitor, atorvastatin, promotes sensorimotor recovery, suppressing acute inflammatory reaction after experimental intracerebral hemorrhage.
    Jung KH; Chu K; Jeong SW; Han SY; Lee ST; Kim JY; Kim M; Roh JK
    Stroke; 2004 Jul; 35(7):1744-9. PubMed ID: 15166393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of heart transplantation on skeletal muscle metabolic enzyme reserve and fiber type in end-stage heart failure patients.
    Pierce GL; Magyari PM; Aranda JM; Edwards DG; Hamlin SA; Hill JA; Braith RW
    Clin Transplant; 2007; 21(1):94-100. PubMed ID: 17302597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elucidation of the mechanism of atorvastatin-induced myopathy in a rat model.
    El-Ganainy SO; El-Mallah A; Abdallah D; Khattab MM; Mohy El-Din MM; El-Khatib AS
    Toxicology; 2016 Jun; 359-360():29-38. PubMed ID: 27345130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antioxidant effects of statins via S-nitrosylation and activation of thioredoxin in endothelial cells: a novel vasculoprotective function of statins.
    Haendeler J; Hoffmann J; Zeiher AM; Dimmeler S
    Circulation; 2004 Aug; 110(7):856-61. PubMed ID: 15289372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells.
    Hernández-Perera O; Pérez-Sala D; Navarro-Antolín J; Sánchez-Pascuala R; Hernández G; Díaz C; Lamas S
    J Clin Invest; 1998 Jun; 101(12):2711-9. PubMed ID: 9637705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atorvastatin inhibition of cytokine-inducible nitric oxide synthase expression in native endothelial cells in situ.
    Wagner AH; Schwabe O; Hecker M
    Br J Pharmacol; 2002 May; 136(1):143-9. PubMed ID: 11976279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of long-term administration of HMG-CoA reductase inhibitor, atorvastatin, on stroke events and local cerebral blood flow in stroke-prone spontaneously hypertensive rats.
    Tanaka N; Katayama Y; Katsumata T; Otori T; Nishiyama Y
    Brain Res; 2007 Sep; 1169():125-32. PubMed ID: 17706949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.